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SUMMARY Sleep disturbances are important correlates of depression, with epidemiologic research
heretofore focused on insomnia and sleepiness. This epidemiologic studys aim was to
investigate, in a community sample, depressions relationships to other sleep
disturbances: sleep paralysis (SP), hypnagogic ⁄hypnopompic hallucinations (HH),
cataplexy – considered rapid eye movement-related disturbances – and automatic
behavior (AB). Although typical of narcolepsy, these disturbances are prevalent, albeit
under-studied, in the population. Cross-sectional analyses (1998–2002), based on
Wisconsin Sleep Cohort Study population-based data from 866 participants (mean age
54, 53% male), examined: depression (Zung Self-Rating Depression Scale), trait anxiety
(Spielberger State-Trait Anxiety Inventory, STAI-T ‡ 75th percentile), and self-
reported sleep disturbances. Descriptive sleep data were obtained by overnight
polysomnography. Adjusted logistic regression models estimated depressions associ-
ations with each (>few times ever) outcome – SP, HH, AB, and cataplexy. Depressions
associations with self-reported SP and cataplexy were not explained by anxiety. After
anxiety adjustment, severe depression (Zung ‡55), vis-à-vis Zung <50, increased SP
odds 500% (P = 0.0008). Depression (Zung ‡50), after stratification by anxiety given
an interaction (P = 0.02), increased self-reported cataplexy odds in non-anxious (OR
8.9, P = 0.0008) but not anxious (OR 1.1, P = 0.82) participants. Insomnia and
sleepiness seemed only partial mediators or confounders for depressions associations
with self-reported cataplexy and SP. Anxiety (OR 1.9, P = 0.04) partially explained
depressions (Zung ‡55) association with HH (OR 2.2, P = 0.08). Anxiety (OR 1.6,
P = 0.02) was also more related than depression to AB. Recognizing depressions
relationships to oft-neglected sleep disturbances, most notably SP, might assist in better
characterizing depression and the full range of its associated sleep problems in the
population. Longitudinal studies are warranted to elucidate mediators and causality.
k e y w o r d s depression, epidemiology, hypnagogic hallucinations, sleep disturbances,
sleep paralysis
INTRODUCTION
Sleep disturbances are well-established correlates of depres-
sion (Breslau et al., 1996; Ford and Kamerow, 1989) and the
most prevalent persisting residual symptoms among antide-
pressant responders (Nierenberg et al., 1999). In clinical
polysomnographic studies, depression has been predicted
(Perlis et al., 1997) and descriptively characterized by sleep
disturbances, including poor sleep (e.g. increased awake-
nings) and rapid eye movement (REM) sleep stage abnor-
malities such as shortened REM sleep latency (Akiskal
et al., 1982; Kupfer and Foster, 1972; Reynolds et al., 1983;
Thase et al., 1984). In epidemiologic studies, depression has
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been associated with increased insomnia and hypersomnia
(Breslau et al., 1996; Ford and Kamerow, 1989) or excessive
daytime sleepiness (Hublin et al., 1996; Ohayon et al., 1997).
Depressions relationships to other sleep-related disturbances
have seldom been investigated in the population. There-
fore, in the present study, we hypothesized that depression
would be more prevalent in individuals with sleep paralysis
(SP), hypnagogic ⁄hypnopompic hallucinations (HH) and
cataplexy – considered dissociated manifestations of REM
sleep (Hishikawa and Shimizu, 1995; Roth et al., 1968a),
and also in automatic behavior (AB) – typified by semi-ABs
and mishaps, and linked clinically to drowsiness periods and
micro-sleeps (Ganado, 1958; Guilleminault et al., 1975).
These sleep-related disturbances, along with sleepiness, are
core clinical symptoms of narcolepsy (Ganado, 1958; Yoss
and Daly, 1957) and usually studied in this context.
However, they often occur in the general population and
non-clinical groups (Billiard et al., 1987; Hublin et al., 1994;
Ohayon et al., 1999; Partinen, 1982; Szklo-Coxe et al., 2007),
and can be triggered in non-narcoleptics by nocturnal disrup-
tions (Takeuchi et al., 1992), sleep debt (Mikulincer et al.,
1989), and sleepiness (Billiard et al., 1987). Despite preval-
ence estimates as high as 15–43% for lifetime sleep paralysis
in undergraduate and medical students (Cheyne et al., 1999;
Everett, 1963; ; Wing et al., 1994), epidemiologic research on
these disturbances psychiatric correlates has heretofore been
scant (Ohayon and Shapiro, 2000; Ohayon et al., 1996,
1999).
Present analyses were based on population-based data
from the Wisconsin Sleep Cohort Study (WSCS), a longi-
tudinal study of the natural history of sleep disorders
(Young et al., 1993). In prior WSCS investigations, self-
reported cataplexy, SP, HH, and AB were not found to be
related significantly to HLA DQB1*0602, a genetic marker
for narcolepsy (Mignot et al., 1997), or consistently to
several of narcolepsys key diagnostic criteria (nocturnal
sleep, sleep onset REM sleep periods) (Mignot et al., 2006;
Szklo-Coxe et al., 2007), suggesting that they are not definite
manifestations of or exclusive to narcolepsy in the popula-
tion and that other correlates warrant consideration. We
presently focus on depression and its relationships to these
disturbances while considering anxiety. Regarded as clinic-
ally useful from prognostic and therapeutic viewpoints
(Clayton et al., 1991; Fava et al., 1997; Paykel, 1972),
depression accompanied by anxiety has been associated with
increased psychiatric impairment and symtomatology (Brown
et al., 1996; Fava et al., 2004; Paykel, 1972; VanValkenburg
et al., 1984), including insomnia (Clayton et al., 1991;
Coryell et al., 1998). Insomnia and sleepiness were presently
considered as potential confounders and ⁄or mediators. They
are outcomes (Roberts et al., 1999) and correlates
(Hublin et al., 1996; Ohayon et al., 1997) of depression
and mood disturbances and have been linked to self-
reported cataplexy, HH and SP (Billiard et al., 1987;
Ohayon et al., 1996, 1999; Szklo-Coxe et al., 2007; Wing
et al., 1994).
METHODS
The sample comprised men and women enrolled in the WSCS,
begun in 1989. WSCSs design has been described previously
(Young et al., 1993). Briefly, its overall sampling frame was an
employee payroll listing of five state agencies in south central
Wisconsin, ages 30–60 years at baseline. A two-stage random-
stratified sampling procedure was used. Participation in the
WSCS includes an overnight sleep study protocol with full
polysomnography (PSG), completion of the Zung Self-Rating
Depression Scale (Zung, 1965) and self-administered Spielber-
ger State-Trait Anxiety Inventory (STAI) (Spielberger et al.,
1983), anthropometric measurements, collection of blood, and
a questionnaire on sleep variables. The protocol is repeated at
4-year intervals, and the sample is periodically surveyed by
mail. The present sample was limited to 866 participants
studied December 1998–2002 on whom complete data from
the overnight protocol, a mailed survey conducted in 2000, and
genotyping on HLA DQB1*0602 as a marker for narcolepsy
susceptibility were available. Depression (measured on the
overnight protocol) and outcomes (measured on the mailed
survey) were thus assessed within ±2 years (December 1998 to
December 2002) of one another.
The University of Wisconsin Health Sciences Institutional
Review Board approved the study protocol and consent
procedures. Participants provided signed informed consent.
The evening of overnight study, participants completed the
Zung Scale and STAI. Eighteen-channel PSG (Grass Heritage
PSG Digital Sleep System with Model 15A54 amplifiers)
included electro-oculography, electroencephalography (EEG),
and electromyography. Sleep stage for each 30-s epoch was
scored blindly by technicians, according to conventional
criteria (Rechtschaffen and Kales, 1968). Sleep latency, REM
sleep latency, percent REM sleep, total sleep time (TST), wake
after sleep onset (WASO), and sleep efficiency measures were
obtained from PSG data. Whole blood was collected the
morning following overnight PSG. DNA was extracted and
samples typed at Stanford University for HLA DQB1*0602s
presence, as previously described (Mignot et al., 1999). On the
mailed questionnaire, participants completed the Epworth
Sleepiness Scale (Johns, 1991) and rated, on Likert scales,
frequency of insomnia, and the outcomes – SP, HH, AB, and
cataplexy items. Possible response categories for outcomes
were (1) never, (2) only a few times ever, (3) rarely: <1 ⁄month,
(4) sometimes: ‡1 ⁄month but <1 ⁄week, (5) often: ‡1 ⁄week.
Presence of each outcome was defined as ever experiencing any
individual item describing that outcome >few times ever – or
responses of 3, 4, or 5 above. Analyses of individual items are
shown in Table 1a. Broadly, increased percentages of depres-
sion were found across increasing severity levels (Table A1b).
SP referred to ever awakening and found you were unable to
move your whole body and felt paralyzed either upon
awakening either in the morning and ⁄or during your nights
sleep. HH, occurring during wake–sleep (hypnagogic)
or sleep–wake (hypnopompic) transitions, referred to ever
imagined that you hear or see strange and frightening things or
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people when falling asleep at night and ⁄or wake up in the
morning and ⁄or are drowsy. Positive response to any of
these items constituted presence. AB referred to ever had times
when you suddenly felt like you ‘‘went blank’’ with no memory
of that period of time either when driving and ⁄or working at
a desk or sitting quietly. Self-reported cataplexy was defined
as ever had episodes of muscle weakness in your legs or
buckling of your knees with ‡1 item(s), each representing a
typical triggering emotion(s): when you laugh and ⁄or are
angry and ⁄or tell or hear a joke (Anic-Labat et al., 1999).
The Zung self-rating depression scale (scaled score range
25–100) measured depression. Zung score ‡50 was considered
indicative of clinical depression (Zung, 1965). Of those with
depressive symptomatology (Zung ‡50), the median (score 54)
was the severity cutpoint, with lesser severity depression
defined as Zung 50–54; greater severity as Zung ‡55. Antide-
pressants were not included in depressions definition because
they are prescribed for SP, HH, and cataplexy (Takahashi,
1976) and our cross-sectional data precluded determining
depressions temporal relationship to antidepressants. Thus,
models: (1) included antidepressants as independent varia-
bles ⁄ confounders; and (2) excluded antidepressant users.
The self-reported trait-anxiety scale of the State-Trait
Anxiety Inventory (STAI-T), scored by summing ratings for
20 items (score range 20–80), measured relatively stable
individual differences in anxiety-proneness (Spielberger et al.,
1983). The 75th percentile, used previously in cohort studies
(Dayan et al., 2002; Frasure-Smith and Lesperance, 2003), was
obtained from the overall sample (n = 1488) as a cutpoint to
define anxiety (STAI-T ‡ 39). Sensitivity analyses using the
‡90th percentile (STAI-T ‡ 46) yielded similar results (Tables
A2a and A2b) to the ‡75th percentile regarding depressions
associations with outcomes.
Medications were categorized according to National Insti-
tute of Mental Health classifications (NIMH, 2002). Antide-
pressant classes included selective serotonin reuptake
inhibitors (SSRIs), tricyclic antidepressants, monoamine oxid-
ase inhibitors, and others. Anxiolytics included alprazolam,
buspirone, clonazepam, diazepam, lorazepam, and oxazepam.
Daytime sleepiness was defined as Epworth Sleepiness Score
(ESS) >11. Four insomnia variables examined (‡5 time-
s ⁄month) were: difficulty getting to sleep, wake up repeatedly
during the night, wake up too early in the morning and cant
get back to sleep, and wake up during the night and have a
hard time getting back to sleep. Other adjustment variables
examined in logistic regression models included age (years),
male, body mass index [BMI, weight (kg) ⁄height (m2), and
DQB1 positivity – or an HLA DQB1*0602 allele, present in
95% of individuals with narcoleptic cataplexy (Mignot et al.,
1997). EEG parameters were: REM sleep latency, defined as
time in minutes (min) from sleep onset to first REM sleep
epoch; percent REM sleep (%), as time in REM sleep ⁄TST;
sleep latency, time (min) from lights off to first occurrence of
stage 2 or REM sleep; TST, as total sleep epochs (30 s each);
WASO, as time (min) awake after first sleep onset; and sleep
efficiency (SE) (%), as TST ⁄ time in bed from lights off.
Statistical analysis
To consider their potential inclusion in logistic regression
models, variables were analyzed by depression status
(Table 1). Significance (P £ 0.05, two sided) was assessed by
Pearsons chi-square for categorical, and pairwise t-tests for
continuous predictors. Pooled or sattertwait t-tests (two sided)
for equal or unequal variances assessed significant differences.
Means of EEG sleep measures (excluding participants on
antidepressants and ⁄or anxiolytics) by depression status are
presented exclusively descriptively to describe sleep patterns by
depressive symptoms. Covariates with significant odds ratios
were entered into multivariable logistic regression models.
Using SAS (SAS Institute Inc., Cary, NC, USA), logistic
regression modeling assessed depressions unadjusted (Table 2)
and adjusted (Tables 4–7) associations with outcomes. The
interaction depression · anxiety was evaluated in models and
not found significant for SP (P = 0.66), HH (P = 0.64), or
AB (P = 0.37). Only for self-reported cataplexy was there a
significant interaction; thus, depression was stratified (rather
than adjusted) by anxiety in these models. For all other
models, depression and anxiety were adjusted for one another.
Odds ratios (ORs) and their 95% confidence intervals (95%
CI) were calculated from beta coefficient estimates obtained
from these models. Associations were considered statistically
significant at P £ 0.05 level (two sided). Principal components
analyses (Varimax rotated solution) suggested outcomes be
modeled separately. Depression was categorized by severity for
most models, except when stratified by anxiety for self-
reported cataplexy (given small sample size). The logistic
regression models included ⁄ excluded the following additional
variables: (A) age, gender, BMI, antidepressant use; (B) model
A variables plus (adjustment for or stratification by) anxiety;
(C) model B variables excluding antidepressant users; (D)
model B variables (adjustment or stratification for/by anxiety)
plus sleepiness and insomnia – hypothesized to be potential
confounders ⁄mediators for self-reported SP and cataplexy, the
outcomes most strongly related to depression.
RESULTS
Of the 866 study sample participants, 118 (13.6%) had
depressive symptoms (Zung score ‡50) (Table 1). Average
age was 54 years and did not differ between Zung categories.
Male gender represented over one-half of the sample, but fewer
men were in the depressed (Zung ‡50) group. Of those with
depressive symptoms, 43.3% had trait anxiety, 41% were on
antidepressants, and 11% on anxiolytics.
The most prevalent outcome was AB (25.1%), and the least,
cataplexy (2.9%). Individuals with Zung ‡50 had higher
prevalences of all sleep disturbances – especially self-reported
SP and cataplexy – when compared with those with Zung <50
(Table 1). Of the 156 participants on antidepressants in the
sample (18%), most were on SSRIs (10.0%) and 31% had
concurrent depressive symptomatology. Participants average
BMI was fairly high (29.4 kg ⁄m2) and similar in depression and
Depression and sleep disturbances 299
 2007 European Sleep Research Society, J. Sleep Res., 16, 297–312
no depression (Zung < 50) groups. Antidepressant and anxio-
lytic use, sleepiness and insomnia symptoms (difficulty falling
asleep and repeated walkings) were more prevalent in partici-
pants with depressive symptoms than those with Zung<50, but
the prevalence ofDBQ1*0602 status did not differ by depression
status. Relative to Zung <50, longer sleep latencies and trends
of increasedWASO, decreased average TST, and lower SE were
observed in depression; while, perhaps unexpectedly, RL was
increased and percent REM sleep similar in depression.
As shown in Table A3, anxiety was related to all outcomes
(P £ 0.02) except SP; sleepiness was significantly related to all
but HH; insomnia symptoms (difficulty falling asleep and
repeated walkings) to all outcomes (P £ 0.05); and genotype
HLA DQB1*0602 to none. Anxiolytics (OR 3.8) and anti-
depressants (OR 3.2) were associated (P £ 0.02) with self-
reported cataplexy; and antidepressants related (P £ 0.02) to
AB (OR 1.8). As DQBI*0602 and anxiolytics were not
confounders for, or independently related to, any outcomes
Table 2 Adjusted associations* of depression and antidepressants with four self-reported sleep disturbances
Sleep paralysis
Hypnagogic ⁄ hypno-
pompic hallucinations Automatic behavior Cataplexy
OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value
Depression (Zung ‡50)
versus no depression (Zung <50)
2.78 (1.37–5.63) 0.005 2.24 (1.24–4.08) 0.008 1.64 (1.07–2.53) 0.03 3.43 (1.42–8.28) 0.006
Antidepressant use versus none 1.45 (0.70–2.98) 0.32 0.98 (0.53–1.82) 0.95 1.55 (1.04–2.30) 0.03 2.19 (0.90–5.35) 0.09
*Also adjusted for age, sex, and body mass index. For models with further adjustments, see Table A4.
No depression refers to no depression symptoms (reference group).
Table 1 Outcomes, covariates, and descriptive sleep characteristics for overall sample and by depression status in Wisconsin Sleep Cohort Study









Frequency 866 748 118
Prevalence (95% CI) (%) 100 86.4 13.6
Age (years) (mean ± SD) 53.6 ± 7.6 53.6 ± 7.6 52.0 ± 7.7
Male (%) 52.9 55.1 39.0
Outcomes (self-reported), >few times ever
Sleep paralysis (%) 5.2 4.1 11.9
Hypnagogic ⁄ hypnopompic hallucinations (%) 8.7 7.5 16.1
Automatic behavior (%) 25.1 23.3 36.4
Cataplexy (%) 2.9 2.0 8.5
Covariates
Trait anxiety (‡75th percentile) (%) 23.2 4.7 43.3
Antidepressant use (%) 18.1 14.6 40.7
Anxiolytic use (%) 3.7 2.5 11.0
Body mass index (kg ⁄m2) (mean ± SD) 29.4 ± 6.2 29.2 ± 6.2 29.4 ± 6.7
Daytime sleepiness: Epworth Sleepiness Score >11 (%) 26.3 23.4 44.9
Insomnia ‡5 ⁄month (%)
Difficulty getting to sleep 15.4 13.4 28.0
Wake up during the night & have a hard time getting back to sleep 21.1 20.1 27.4
Wake up repeatedly during the night 32.6 30.6 45.3
Wake up too early in the morning & cannot get back to sleep 18.8 17.8 24.6
Narcolepsy allele(s), genotype HLA DQB1*0602 (%) 24.1 24.5 22.0
Descriptive sleep variables: EEG nocturnal measures (mean ± SD)
Sleep latency (min) 12.0 ± 13.8 11.8 ± 13.9 13.4 ± 12.6
REM sleep latency (min) 107.9 ± 56.1 106.7 ± 55.4 118.5 ± 61.2
Percent REM sleep (%) 18.5 ± 5.7 18.6 ± 5.6 18.2 ± 6.0
Total sleep time (min) 375.0 ± 56.2 375.1 ± 55.3 374.4 ± 63.9
Wake after sleep onset (min) 65.4 ± 38.4 65.0 ± 37.4 69.0 ± 47.1
Sleep efficiency (%) 82.1 ± 9.4 82.2 ± 9.2 80.9 ± 11.0
Zung, Zung Self-Rating Depression Scale; STAI-T, trait scale of Spielberger State-Trait Anxiety Inventory; ‡75th percentile, upper quartile or
score ‡39; EEG, electroencephalographic sleep measured by polysomnography; REM, rapid eye movement; HLA, human leukocyte antigen.
Means with additional exclusions – sedatives and ⁄ or stimulants, WASO ‡200 min, SE <0.5%, RL <0 min, RL >400 min, SL >60 min, were
similar to findings shown.
Significant differences (two-sided test) at P £ 0.05 for Zung score ‡50 versus Zung score <50.
For EEG sleep variables, participants on antidepressants and ⁄ or anxiolytics were excluded (n = 599).
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in adjusted models, they were not included in final models
presented but are shown in Table A4. By contrast, in adjusted
models, antidepressants were confounders for and related to
self-reported cataplexy and AB, and thus were included.
With antidepressants, age, sex, and BMI adjustments
(Table 2), depressive symptomatology combining lesser and
greater severity (versus Zung < 50), was significantly related
to all outcomes, with the strongest association seen for
cataplexy (OR 3.43, P = 0.006). The Zung depression scale
incorporates two items (I get tired for no reason and I have
trouble sleeping through the night) related to tiredness and
insomnia which might create built-in associations and obfus-
cate relationships. In sensitivity analyses, similar relationships
(not shown in Tables) were found when a modified Zung scale
without these items was used. Upon adjustment for age,
gender, BMI, and depression, antidepressants were also
associated independently with cataplexy (albeit non-signifi-
cantly) and AB (P = 0.03).
Of participants with Zung ‡50, 58.5% had lesser, and 41.5%
greater severity depression, representing 8.0% and 5.7% of the
sample respectively (Table 3). Prevalences of sleep-related
disturbances, particularly SP, were higher in those with greater
severity of depression symptoms. All outcomes were more
prevalent in anxiety, suggesting anxiety warranted considera-
tion alongside depression.
Main adjusted models
Tables 4–7 show results of models describing, mostly, the
relationships of depression severity to sleep-related outcomes,






Basic model (C) adjusted







OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value
Depression
No depression
(Zung score <50, reference)
1.00 1.00 1.00 1.00
Lesser severity depression
(Zung score 50–54)
1.62 (0.60–4.41) 0.35 1.85 (0.62–5.47) 0.27 2.52 (0.73–8.68) 0.14 1.54 (0.52–4.60) 0.44
Greater severity depression
(Zung score ‡55)
4.95 (2.05–11.99) 0.0004 5.81 (2.08–16.18) 0.0008 6.16 (1.54–24.67) 0.01 4.48 (1.55–12.98) 0.006
Antidepressant use versus none 1.33 (0.90–0.98) 0.45 1.36 (0.64–2.87) 0.43 N ⁄A 1.38 (0.64–2.96) 0.41
Trait anxiety (STAI-T ‡75th)
versus STAI-T <75th
1.02 (0.98–1.07) 0.33 1.04 (0.99–1.09) 0.10 0.75 (0.33–1.72) 0.50
Daytime sleepiness





OR, odds ratios; CI, confidence intervals; STAI-T ‡75, 75th percentile (score of ‡39) on Trait-Anxiety Scale of Spielberger State-Trait Anxiety
Inventory; ESS, Epworth Sleepiness Score; NA, not applicable. Depression refers to depressive symptomatology. In models A, B, and D, there were
45 participants with sleep paralysis; in model C there were 32 participants with sleep paralysis.
*Odds ratios estimated from four logistic regression models and also adjusted for age, sex, body mass index (BMI) in kg ⁄ height (m2).
P-trend = 0.001 for relationship of depression severity to sleep paralysis.
Insomnia (self-reported) defined as waking up repeatedly during the night.








Greater severity of symptoms (Zung score ‡55) (n = 49) 18.4 20.4 42.9 10.2
Lesser severity of symptoms (Zung score 50–54) (n = 69) 7.2 13.0 31.9 7.3
No depression (Zung score <50, reference) (n = 748) 4.1 7.5 23.3 2.0
Trait anxiety (STAI-T ‡ 75th percentile) (n = 665) 7.5 15.4 35.8 6.0
No trait anxiety (STAI-T <75th percentile, reference) (n = 201) 4.5 6.6 21.8 2.0
All values are in percentages. STAI-T, Trait Scale of Spielberger State-Trait Anxiety Inventory.
*P-values £0.005 for all four outcomes from Mantel–Haenszel chi-squared tests comparing greater severity depression, lesser severity depression,
and no depression.
P-values £0.003 for hypnagogic ⁄ hypnopompic hallucinations, automatic behavior, and cataplexy from Mantel–Haenszel chi-squared tests
comparing anxiety to no anxiety.
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with further adjustment or stratification for ⁄by anxiety
(B–D models), exclusions of antidepressant users (C models),
and additional adjustment for sleepiness and insomnia
(D models) – potential confounders or mediators only for
self-reported SP and cataplexy. Depression of lesser severity
(Zung 50–54) was associated only with self-reported cataplexy.
Thus, the following description of results focuses on depres-
sion of greater severity (Zung ‡55).
Sleep paralysis
Depression of greater severity was strongly associated with
SP (OR 5.0) upon simultaneous adjustment for antidepres-
sant use, age, sex and BMI (model A) (Table 4). This
relationship became even stronger with additional adjust-
ment for anxiety (model B) (OR 5.8, P = 0.0008) or
excluding persons on antidepressants (model C) (OR 6.2,






Basic model (C) adjusted
for anxiety and excluding
antidepressant users
(n = 709)
OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value
Depression
No depression (Zung <50, reference) 1.00 1.00 1.00
Lesser severity depression (Zung 50–54) 1.72 (0.79–3.72) 0.17 1.23 (0.53–2.83) 0.64 1.23 (0.34–3.33) 0.69
Greater severity depression (Zung ‡55) 3.20 (1.43–7.14) 0.005 2.19 (0.91–5.25) 0.08 0.78 (0.16–3.74) 0.75
Antidepressant use versus none 0.94 (0.50–1.75) 0.84 0.88 (0.46–1.65) 0.70 N ⁄A
Trait Anxiety  (STAI-T ‡75th) versus STAI-T <75th 1.87 (1.04–3.37) 0.04 1.76 (0.90–3.47) 0.10
OR, odds ratios; CI, confidence intervals; STAI-T, Trait-Anxiety Scale of Spielberger State-Trait Anxiety Inventory; NA, not applicable. In models
A and B, there were 75 participants with hypnagogic ⁄ hypnopompic hallucinations (HH); in model C, there were 58 participants with HH.
*Odds ratios estimated from three logistic regression models and also adjusted for age, sex, body mass index (BMI) in kg ⁄ height (m2).
P-trend = 0.09 for relationship of depression severity to hypnagogic ⁄ hypnopompic hallucinations.
Trait-anxiety measured as STAI-T ‡75th percentile (score of ‡39) versus <75th percentile (score of <39).
Table 5b Percentages of hypnagogic ⁄
hypnopompic hallucinations by depression
status stratified by antidepressant users
Hypnagogic ⁄ hypnopompic hallucinations
No antidepressant
users (n = 709),
n (%)
Only antidepressant
users (n = 157),
n (%)
No depression (Zung score <50, reference 54) 50 (7.82) 6 (5.50)
Lesser severity depression (Zung score 50–54) 6 (13.04) 3 (13.04)
Greater severity depression (Zung score ‡55) 2 (8.33) 8 (32.0)






Basic model (C) adjusted
for anxiety excluding all
antidepressant users
(n = 709)
OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value
Depression
No depression (Zung score <50, reference) 1.00 1.00 1.00
Lesser severity depression (Zung score 50–54) 1.38 (0.80–2.38) 0.25 1.08 (0.60–1.94) 0.81 1.22 (0.60–2.49) 0.58
Greater severity depression (Zung score ‡55) 2.10 (1.13–3.91) 0.02 1.58 (0.82–3.09) 0.18 1.67 (0.67–4.19) 0.27
Antidepressant use versus none 1.52 (1.02–2.26) 0.04 1.45 (0.97–2.16) 0.07 N ⁄A
Trait anxiety (STAI-T ‡75th) versus STAI-T <75th 1.60 (1.07–2.39) 0.02 1.81 (1.13–2.91) 0.01
OR, odds ratios; CI, confidence intervals; BMI, body mass index; STAI-T, Trait-Anxiety Scale of Spielberger State-Trait Anxiety Inventory; N ⁄A,
not applicable. In models A and B, there were 217 participants with automatic behavior (AB); in model C there were 163 participants with AB.
*Odds ratios estimated from three logistic regression models and also adjusted for age, sex, body mass index (BMI) in kg ⁄ height (m2).
P-trend = 0.40 (not statistically significant) for relationship of depression severity to automatic behavior.
Trait anxiety measured as STAI-T ‡75th percentile (score of ‡39) versus <75th percentile (score of <39).
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P = 0.01), and persisted after further adjustment for
daytime sleepiness and insomnia (model D) (OR 4.5,
P = 0.006), even when a modified Zung scale was used
(OR 4.8, P = 0.006). Insomnia – but not antidepressant
use, anxiety, or daytime sleepiness – was also found to
be independently related to SP (model D, OR 2.5,
P = 0.004).
Hypnagogic ⁄ hypnopompic hallucinations
Compared with non-depressed participants, depression of
greater severity was related to a 3.2-fold increase in the odds
of HH after adjustment for antidepressant use, age, sex
and BMI (Table 5a, model A). This positive association
became weaker (OR 2.2) with the addition of anxiety
(model B), also independently related to HH (OR
1.9, P = 0.04); and disappeared with the exclusion of
antidepressant users (model C). Further analyses
(Table 5b) suggested that, in antidepressant users,
percentages of HH increased with depression symptom
severity, but that, in non-antidepressant users, the HH
prevalence in the highest severity group resembled that in no
depression.
Automatic behavior
Compared to individuals without depression, greater severity
of depression symptoms was associated with two-fold in-
creased odds of AB upon adjustment for antidepressants, age,
gender and BMI (Table 6). This association became weaker
and non-significant after adjustment for anxiety (model B),
suggesting anxiety explained, at least partially, depressions
relationship to AB. Excluding participants on antidepressants
(model C) did not alter results more than adjusting for anxiety.
Anxiety was found to be independently and significantly
related to AB (models B and C). Adjusting for age, sex, BMI,
anxiety, antidepressant use was also related, although only
with borderline significance (P = 0.07), to AB (model B).
Self-reported cataplexy
Both lesser and greater severity depression were strongly
associatedwith cataplexy, after adjustments for antidepressants,
age, gender, and BMI (Table 7a, model A). The only sleep-
related outcome for which the interaction depression · anxiety
was significant was self-reported cataplexy (P = 0.02) (Table
A6), thus making it inappropriate to adjust for anxiety when
Table 7a Adjusted associations* of
depression and antidepressants with
self-reported cataplexy (model A)
Odds ratio 95% CI P-value
Depression
No depression (Zung score <50, reference) 1.00
Lesser severity depression (Zung score 50–54) 3.07 (1.05–8.99) 0.04
Greater severity depression (Zung score ‡55) 4.00 (1.27–12.38) 0.02
Antidepressants versus none 2.14 (0.87–5.29) 0.10
CI = confidence intervals.
*Also adjusted for age, sex, and body mass index (BMI) in kg ⁄ height (m2).
There were 25 participants with self-reported cataplexy.
P-trend = 0.007 for relationship of depression severity to self-reported cataplexy.














OR* (95% CI) P-value OR* (95% CI) P-value OR* 95% CI P-value
In participants without anxiety (STAI-T <75th)
Depression (Zung ‡50) versus no depression 8.85 (2.46–31.94) 0.0008 9.30 (1.75–49.40) 0.009 4.89 (1.28–18.67) 0.02
In participants with anxiety (STAI-T ‡75th)
Depression (Zung ‡50) versus no depression 1.14 (0.34–3.82) 0.82 0.80 (0.14–4.68) 0.80 0.86 (0.25–3.00) 0.82
OR, odds ratios; CI, confidence intervals; STAI-T, Trait-Anxiety Scale of Spielberger State-Trait Anxiety Inventory. In models B and D, there were
25 participants with self-reported cataplexy; in model C there were 15 participants with self-portrait cataplexy.
*Odds ratios estimated from logistic regression models and also adjusted for age, sex, and body mass index in kg ⁄ height (m2).
Depression severity categories used in other models were collapsed into Zung ‡50 given the small sample size and similar relationships of lesser and
greater severity depression to this outcome.
P-values for interaction terms for depression · anxiety (trait) were 0.02 for model B, 0.05 for model C, and 0.06 for model D.
§Sleepiness (daytime) defined as an Epworth Sleepiness Score >11 (versus £11); Insomnia (self-reported) defined as waking up repeatedly during
the night ‡5 ⁄month (versus £4 ⁄month).
–No depression refers to no depressive symptoms (Zung < 50). Its odds ratio is 1.00.
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assessingdepressions relationship to cataplexy (seeTableA7 for
rates). When depression was stratified by anxiety (Table 7b,
model B), power was not sufficient to categorize depression by
severity. Overall depression (Zung ‡50) in non-anxious partic-
ipants was highly significantly related to an almost ninefold
increase in self-reported cataplexy odds (model B). This associ-
ation became stronger after excluding persons on antidepres-
sants (model C). However, upon simultaneous adjustment for
model B variables plus sleepiness and insomnia, the odds ratio
decreased to 4.9 (P = 0.02). Nevertheless, the relationship was
still strong, even when a modified Zung scale was used (OR 5.7,
P = 0.01). By contrast, no relationship was seen between
depression and self-reported cataplexy in anxious participants in
any of the models. Anxiety without depression was also related
to cataplexy (OR 3.2, P = 0.03) (Table A6, estimated from
interaction model B).
Secondary analyses
We conducted a broad, limited (as outcomes were not
necessarily concurrent) test of discriminant validity to examine
depressions relationships to SP, without and with HH, and of
HH, without and with SP (Tables A5a and A5b). Even in the
subgroup without HH, SP was strongly related to depression
(OR 3.0, 95% CI 1.4–6.5), as in the overall sample (OR 3.1). In
the subgroup with HH, SP was less strongly (and non-
significantly), related to depression (OR 2.2). Similarly, in the
subgroup without SP, depression was related to HH (OR 2.3),
which is similar to that in the overall sample (OR 2.4). In the
subgroup with SP, depression was related more weakly to HH,
perhaps due to lower precision (OR 1.7).
DISCUSSION
In our population-based investigation, depressive symptoma-
tology was strongly related to SP and to self-reported
cataplexy, and these associations were not explained by
anxiety in depression. Depression, however, was related less
strongly to HH, with anxiety (independently related to HH)
partly explaining this relationship. Moreover, anxiety was
more strongly related to AB than depression.
Present findings reveal the magnitude of depressions
association with SP and are broadly consistent with the
increased percentage of depressive disorders found in partic-
ipants with SP (although non-significant with adjustments)
and bipolar disorders relationship (adjusted) to SP (Ohayon
et al., 1999). Our findings are also generally consistent with
case reports of SPs links to reactive depression (Gangdev and
Ramjee, 1996) and depressive states in familial SP (Roth et al.,
1968b). Present findings might also suggest that SP shares
pathophysiologic mechanisms with depression. A panic disor-
der-SP link has been previously reported (Bell et al., 1986;
Hinton et al., 2005; Paradis et al., 1997). Also, as with
depression (Kendler et al., 1999), a familial occurrence has
been reported for SP outside of narcolepsy (Bell et al., 1986;
Roth et al., 1968b).
Anxiety did not change depressions associations with SP
and was not related to SP, unlike other reports (Hinton et al.,
2005; Ohayon and Shapiro, 2000). This may be due to our
investigation of general trait anxiety, rather than a specific
disorder like post-traumatic stress disorder, and ⁄or our
predominantly Caucasian sample, e.g. SP more prevalent in
African Americans with panic disorder (Bell et al., 1986).
In participants without anxiety, depression was associated
with an increased prevalence odds of self-reported cataplexy.
In participants with anxiety, however, depression and self-
reported cataplexy were not associated. This finding suggests
that depression without anxiety (non-anxious depression) may
represent a distinct depression subtype (Fava et al., 1997), and
individuals with pure depression (or pure anxiety) may be
more susceptible to cataplexy episodes than individuals with
comorbid disorders. Pure depression, depression with anxiety,
and pure anxiety have often been differentiated, e.g. by
cognitive specificity (Duzois and Dobson, 2001) or EEG
profiles (Akiskal et al., 1984). In our study, depressions
association with cataplexy was not explained by anxiety in
depression.
Although isolated cataplexy has been previously reported in
non-narcoleptics (Hartse et al. 1988), and in sleepy under-
graduates and army draftees (Billiard et al., 1987; Wing et al.,
1994), its relationship to depression has not been studied to
date. Our findings on cataplexy may support the affective
spectrum disorder proposal: cataplexy has been hypothesized
by Hudson and Pope (1990) to share a common pathophys-
iology with depression, including response to many antide-
pressant classes (Hudson and Pope, 1990; Hudson et al.,
2003), although the aforementioned study (Hudson et al.,
2003) had insufficient data to test the hypothesis regarding
cataplexy and its coaggregation with depression.
Findings that anxiety and depression, although not consis-
tently in all models, were related to HH generally agree with
prior Canadian and European findings of HH linked to mood
and anxiety disorders (Ohayon et al., 1996, 1999). Our findings
for HH may extend findings of depression with anxiety related
to worsened symptomatology and outcomes including in-
creased insomnia, depersonalization ⁄derealization (Clayton
et al., 1991; Coryell et al., 1998; Paykel, 1972; VanValkenburg
et al., 1984), hypochondriasis (VanValkenburg et al., 1984),
autonomic (Lenze et al., 2000) and somatic symptoms (Clay-
ton et al., 1991). Derealization might also reflect AB, described
as trance-like or fugue-like, twilight state episodes, and
characterized by amnesia (Ganado, 1958; Guilleminault et al.,
1975).
Epidemiologic studies have previously found depression to
be strongly related to self-reported insomnia and ⁄or sleepiness
(Ford and Kamerow, 1989; Hublin et al., 1996; Ohayon et al.,
1997), consistent also with our findings, although this was not
a specific hypothesis. EEG sleep measures pertaining to
difficulty initiating and maintaining sleep (longer sleep laten-
cies, poorer sleep continuity) revealed trends (albeit not
statistically significant) in our depressed participants consistent
with reports in other depressed patients (Kupfer et al., 1982;
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Reynolds et al., 1983) and with increased self-reported
insomnia in our participants. Decreased sleep efficiency, an
abnormal sleep profile typifying depression (Thase et al., 1997),
was also found in our participants. Most sleep parameters did
not significantly differ by Zung depression status, consistent
with prior findings that as many as 55% of depressed
outpatients have normal EEG sleep profiles resembling those
of healthy controls (Thase et al., 1997). Certain expected
differences in polysomnographic results (e.g. REM sleep
latency or percent REM sleep) (Akiskal et al., 1982, 1984;
Kupfer and Foster, 1972; Reynolds et al., 1983; Thase et al.,
1984) were not presently observed, perhaps due to our
examining community-based participants with predominantly
minimal-mild depressive symptomatology. Of our sample, 12%
had minimal-mild depressive symptomatology (Zung 50–59),
representing 87% of those with Zung-defined depression.
The weakening of depressions relationships to self-reported
SP and, especially, cataplexy upon addition of insomnia and
sleepiness to the models suggest that they are confounders or
mediators for these associations (model D, Table 4; model C,
Table 7b). SP has been previously linked to interrupted and
non-restorative sleep (Ohayon et al., 1999; Takeuchi et al.,
1992; Wing et al., 1994). Depression may underlie poor sleep
and insomnia, which may then lead to SP. Cataplexy-like
episodes have been linked to sleepiness in non-clinical popu-
lations (Billiard et al., 1987; Ohayon et al., 1996; Szklo-Coxe
et al., 2007; Wing et al., 1994). Notwithstanding our datas
cross-sectional nature, marked decreases of depressions esti-
mates with insomnia and sleepiness suggest that these might be
mediators. However, associations remained strong, suggesting
other explanations are also likely and warrant investigation.
Cross-sectional data precluded ascertaining whether depres-
sion improved with antidepressants. Thus, our definition of
depression (Zung ‡50) did not include antidepressants. Find-
ings may therefore even underestimate depressions relation-
ships to SP and self-reported cataplexy. Antidepressants were
found to be related to, and confounders for, depressions
relationships to AB and cataplexy, consistent with cataplexys
favorable clinical response to antidepressants (Takahashi,
1976). Depressions relationships to all outcomes but HH
were similar whether antidepressants were adjusted for or
antidepressant users excluded, suggesting these relationships
were not due to antidepressants. Depressions association with
HH only in antidepressant users (Table 5a) is difficult to
interpret; the timeline regarding its appearance pre- or
post-anti-depressant use cannot be established cross-section-
ally. A possible interpretation, especially as antidepressants
were not related to HH, is that removing antidepressants users
removed more severely depressed participants.
Although the Zung has limitations, such as lack of corres-
pondence to DSM-IV depression, it is correlated with clinical
patient evaluation (Zung, 1965). Active depressive symptoma-
tology was our primary interest given our community-based
sample and predominantly mild depression characterizing
participants. STAI, designed to measure anxiety symptoms
in community-based samples such as ours, corresponds to
clinical domains for Generalized Anxiety Disorder by DSM-IV
criteria, supporting its current applicability (Okun et al.,
1996). Nevertheless, its trait scale may not differentiate
between anxiety and depression constructs and may instead
measure depression and negative effect (Bieling et al., 1998;
Endler et al., 1992). However, if STAI-T were also measuring
depression, one would not expect the association of depression
with cataplexy to be present only in participants without
anxiety (Table 7b).
Our studys strengths overall include use of accepted
(reliable and valid) self-report instruments in a large commu-
nity-based sample and thorough examination of depression
and anxiety after multiple adjustments. Although the Zung
scale is considered a good clinical depression measure,
questionnaire assessments may decrease the clinical implica-
tions of findings. Automatic behavior, in particular, is difficult
to assess via questionnaire, especially if related to sleep
disorders or other medical problems, although physicians
may also experience difficulties diagnosing these disturbances
in patients. A key limitation of this study is its cross-sectional
design, precluding assessment of temporal relationships and
untangling whether sleepiness and insomnia were mediators or
confounders. Our study could not elucidate causal relation-
ships and uncover underlying mechanisms, such as whether
outcomes were specific to REM sleep. Nevertheless, presently
reported associations are meaningful irrespective of whether
outcomes are REM sleep specific, as they extend research on
depressions relationships to sleep-related disturbances seldom
examined, especially outside narcolepsy. Findings are therefore
more than theoretically relevant and generally consistent with
previous limited work on these disturbances and their psychi-
atric correlates.
Hypnagogic ⁄hypnopompic hallucinations (HH) were
assessed when falling asleep at night and waking up in the
morning, but not in the middle of the night. The questions on
HH incorporated strange or frightening in their descriptions;
therefore, participants who experienced HH without this
affective component may have been excluded. Our definition
was also limited to visual, auditory, and affective modalities.
HH occurring with smell (Maury, 1848), motor (Hollingworth,
1911), tactile (Ohayon and Shapiro, 2000), or movement
sensations (e.g. falling), or feeling of sensed presence (Cheyne
et al., 1999) were not assessed. Measuring these sensations may
have led to a more complete assessment of these disturbances
in our study.
Sleep paralysis and HH often co-occur (Cheyne et al.,
1999). HH without SP may have been more likely to
increase reporting of entoptic hallucinations unrelated to
REM sleep, although the affective dimension of the question
may have reduced reporting of these. Our broad test of
discriminant validity suggested HH in SP was not respon-
sible for depressions strong relationship to SP, and SP in
HH did not explain depressions weaker association with
HH. Moreover, depression was related differently (more
strongly) to SP than to HH, indirectly suggesting discrimi-
nant validity.
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Another potential problem in our study is that depressed
subjects may lack a positive self-schema (Duzois and Dobson,
2001) or have cognitive biases favoring negative self-related
information or interpretations of ambiguous situations (Nunn
et al., 1997). This interconnected negative self-representational
system, leading to biased information processing (Duzois and
Dobson, 2001), may have resulted in depressed participants
overestimating the investigated sleep disturbances. However, it
is not clear whether this bias would have affected sleep
disturbance reporting, as this outcome has not been specifically
studied to date with respect to cognitive interference effects.
Given depressed (including with anxiety) participants tenden-
cies to recall less positive information (Duzois and Dobson,
2001) and process more negative information (Nunn et al.,
1997), it is possible HH – defined as strange and frightening –
might have been over-recalled. If depressed participants had
positive emotions less frequently, they might have under-
reported cataplexy, for cataplexy was defined as muscle
weakness triggered by emotions, and positive emotion is the
most sensitive trigger of cataplexy (Anic-Labat et al., 1999;
Krahn et al., 2005). However, findings including and excluding
the anger (negative emotion) item were similar (Table A8).
Depressed participants recalling of less positive information
might be interpreted as automatic behavior, resulting in its
overestimate, a lesser concern, however, given depressions
weaker relationship to this outcome. In any event, without a
sleep expert confirming participants claims, the outcomes
could have been overestimated given depressed patients
propensity for negative processing bias. Nevertheless, similar
clinical and questionnaire-assessed estimates of these symp-
toms have been reported (Bassetti and Aldrich, 1997).
Depression (assessed on the overnight protocol) and out-
comes (from mailed survey) were evaluated within ±2 years of
one another, a limitation of our study. Also, outcome item
questions asked about ever experiencing a disturbance and did
not differentiate between outcomes occurring (infrequently to
frequently) presently versus in the past. In narcolepsys natural
history, the sleep disturbances examined are considered
intermittent – occurring briefly, vanishing, and recurring later
(Billiard et al., 1983; Passouant and Billiard, 1976). Although
we did not study narcoleptics, similar problems may apply as
we did not specify a time frame. Frequent SP, for example,
could refer to the present or some (unspecified) time in the
past. Thus, SPs association with depressive symptoms (gen-
erally, day-to-day) within a 2-year time frame refers to when
outcome items were completed rather than when they
occurred.
We extend epidemiologic findings on depression-sleep dis-
turbances beyond insomnia and sleepiness to SP and self-
reported cataplexy, which may assist in better recognizing and
describing depression in the community. Relationships of
anxiety to HH and AB, and of depression, albeit less strong, to
HH also suggest psychiatric correlates of these sleep distur-
bances, particularly anxiety, warrant attention.
Depressions heavy burden includes its chronic nature (Judd
et al., 1997), considerable symptom severity, role impairment
(Andrade et al., 2003; Kessler et al., 1997), and hidden costs
like lost productive time (Stewart et al., 2003). Ford and
Kamerow (1989) suggest that inquiry regarding sleep distur-
bances might enhance recognition of depression by health
providers, a recommendation that might be extended, in
particular, to SP. Future longitudinal epidemiologic studies on
these and other rarely studied sleep problems may be warran-
ted to better characterize the full range of sleep disturbances
with which depression – alone or comorbid with anxiety – may
be associated in the population. Evolution of the sleep
disturbances investigated with respect to recurrences and
changes in depression and anxiety merits further inquiry in
the population.
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APPENDICES
















In the morning 770 (88.9) 81 (9.4) 11 (1.3) 3 (0.35) 1 (0.12)
During nights sleep 643 (74.3) 182 (21.0) 26 (3.0) 12 (1.4) 3 (0.35)
Hypnagogic ⁄ hypnopompic hallucinations
When falling asleep at night 682 (78.8) 126 (14.6) 38 (4.4) 17 (2.0) 3 (0.35)
When awakening in morning 786 (90.8) 58 (6.7) 14 (1.6) 7 (0.81) 1 (0.12)
When drowsy 771 (89.1) 70 (8.1) 13 (1.5) 10 (1.2) 1 (0.12)
Automatic behavior
When driving 366 (42.4) 312 (36.1) 104 (12.0) 61 (7.1) 21 (2.4)
When working desk ⁄ sitting quietly 485 (56.1) 485 (30.2) 67 (7.8) 39 (4.5) 13 (1.5)
Cataplexy
With laughter 795 (91.8) 57 (6.6) 8 (0.92) 4 (0.46) 2 (0.23)
With anger 801 (92.5) 49 (5.7) 10 (1.2) 4 (0.46) 2 (0.23)
With joking 811 (93.9) 41 (4.8) 7 (0.81) 3 (0.35) 2 (0.23)
















In the morning 96 (12.5) 14 (17.3) 6 (54.6) 1 (33.3) 1 (100.0)
During nights sleep 81 (12.6) 26 (14.3) 4 (15.4) 6 (50.0) 1 (33.3)
Hypnagogic ⁄ hypnopompic hallucinations
When falling asleep at night 85 (12.5) 18 (14.3) 12 (31.6) 1 (5.9) 2 (66.7)
When awakening in morning 100 (12.7) 12 (20.7) 4 (28.6) 1 (14.3) 1 (100)
When drowsy 98 (12.7) 15 (21.4) 3 (23.1) 1 (10.0) 1 (100)
Automatic behavior
When driving 47 (12.8) 33 (10.6) 17 (16.4) 12 (19.7) 8 (38.1)
When working at desk ⁄ sitting quietly 55 (11.3) 35 (13.4) 14 (20.9) 9 (23.1) 4 (30.8)
Cataplexy
With laughter 100 (12.6) 57 (19.3) 8 (19.3) 4 (62.5) 2 (50.0)
With anger 98 (12.2) 14 (28.6) 5 (50.0) 0 (0.0) 1 (50.0)
When joking 106 (13.1) 7 (17.1) 3 (42.9) 1 (33.3) 1 (50.0)
Table A2a Adjusted* associations of depression, categorized by severity, and trait anxiety (‡90th percentile), with self-reported sleep paralysis,
hypnagogic ⁄ hypnopompic hallucinations and automatic behavior
Sleep paralysis (SP)
Hypnagogic ⁄ hypnopompic
hallucinations (HH) Automatic behavior (AB)
Odds ratio (95% CI) P-value Odds ratio (95% CI) P-value Odds ratio (95% CI) P-value
Depression
Zung score <50 (reference) 1.00 1.00 1.00
Lower severity (Zung ‡55) 1.62 (0.56–4.69) 0.37 1.17 (0.49–2.77) 0.72 1.28 (0.71–2.29) 0.42
Higher severity (Zung 50–54) 4.97 (1.79–13.79) 0.002 1.90 (0.75–4.82) 0.18 1.87 (0.93–3.74) 0.08
Anxiety (STAI-T ‡90th) vs. <90th 0.99 (0.37–2.65) 0.99 2.51 (1.19–5.32) 0.02 1.25 (0.70–2.22) 0.45
Antidepressant use vs. none 1.33 (0.63–2.81) 0.46 0.87 (0.46–1.65) 0.67 1.50 (1.01–2.23) 0.05
Age 0.94 (0.89–0.98) 0.003 0.94 (0.91–0.98) 0.0009 0.97 (0.95–0.99) 0.002
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hallucinations (HH) Automatic behavior (AB)
Odds ratio (95% CI) P-value Odds ratio (95% CI) P-value Odds ratio (95% CI) P-value
Female vs. male 0.82 (0.43–1.55) 0.54 1.38 (0.83–2.27) 0.21 0.94 (0.68–1.30) 0.69
Body mass index (kg ⁄m2) 1.02 (0.98–1.07) 0.32 1.01 (0.98–1.05) 0.46 1.03 (1.01–1.05) 0.04
CI, confidence interval, STAI-T, Trait-Anxiety Scale of Spielberger State-Trait Anxiety Inventory. Interpretrations: analyses using ‡90th
percentiles yielded similar results with respect to their effects on depressions associations with the outcomes above, as compared with ‡75th
percentiles. Specifically, depressions relationships to SP were not explained by anxietys presence and anxiety still partially explained depressions
relationship to HH. Although anxiety lowered depressions estimate for AB to non-significance, the confidence intervals were similar to ‡75th
percentile. Anxiety ‡90th percentile was not associated significantly with AB. Cross tabulations indicated that there were many anxious participants
in the 75th–90th percentile (mildly anxious) and when these became part of the <90th reference, the difference with the ‡90th became negligible
(not significant).
*Odds ratios from multiple logistic regression models.
Trait anxiety measured as STAI-T ‡90th percentile (STAI-T score ‡46).
Table A2b Adjusted relationships* (from depression · anxiety interaction model) of depression stratified by trait-anxiety (‡90th percentile) to self-
reported cataplexy (n = 866)
Odds ratio
In participants without anxiety (STAI-T<90th), depression (Zung ‡50) versus no 4.59
In participants with anxiety (STAI-T<90th), depression ‡50 versus no 0.52
STAI-T, Trait-Anxiety Scale of Spielberger State-Trait Anxiety Inventory. Depression categories of severity (Zung score 50–54, and Zung score
‡55) used in other models were collapsed for this model into Zung score ‡50 given small sample size and similar relationships of lesser and greater
severity depression to this outcome. Interpretations: as with the STAI-T ‡75th percentile, depressions relationship to cataplexy persisted in
participants without anxiety (STAI-T ‡90th).
*Multivariable logistic regression model also adjusted for age, sex, body mass index, antidepressant use.
No depression symptoms (Zung <50) is the reference category (odds ratio is 1.00).
P-value for interaction term (from model) for depression · anxiety (trait) is 0.02.
Table A3 Percentages of self-reported sleep disturbance outcomes and their unadjusted odds ratios*, (95% confidence intervals) for predictors
other than depression in the Wisconsin Sleep Cohort Study (n = 866)
Sleep paralysis
Hypnagogic ⁄ hypno-
pompic hallucinations Automatic behavior Cataplexy
% OR (95% CI) % OR (95% CI) % OR (95% CI) % OR (95% CI)
Anxiety (STAI-T ‡75th percentile) vs. <75th 7.46 1.71 (0.90–3.24) 15.42 2.57* (1.58–4.20) 35.82 2.00* (1.42–2.81) 5.97 2.18* (1.43–7.10)
Antidepressant use (n = 157) vs. none 8.28 1.91 (0.98–3.73) 10.83 1.36 (0.77–2.41) 34.39 1.76* (1.21–2.55) 6.37 3.15* (1.39–7.14)
Anxiolytic use (n = 32) vs. none 6.25 1.22 (0.28–5.29) 6.25 0.69 (0.16–2.96) 34.38 1.60 (0.76–3.38) 9.38 3.81 (1.08–13.45)
DQB1-0602 positive (n = 209) vs. negative 6.70 1.45 (0.75–2.77) 8.13 0.91 (0.52–1.60) 26.32 1.10 (0.77–1.56) 2.39 0.78 (0.28–2.10)
Frequent insomnia (‡5 ⁄month) vs. £4 ⁄month
Difficulty falling asleep (n = 133) 10.53 2.65* (1.37–5.13) 17.29 2.73* (1.60–4.64) 35.34 1.80* (1.21–2.67) 6.02 2.68 (1.13–6.35)
Wake up repeatedly during night (n = 282) 8.90 2.74* (1.49–5.02) 11.39 1.65 (1.02–2.68) 32.03 1.70* (1.24–2.34) 4.63 2.30 (1.04–5.11)
Sleepiness: ESS>11 vs. £11 (n = 228) 7.89 1.94 (1.05–3.59) 10.09 1.26 (0.76–2.12) 35.09 1.98* (1.42–2.75) 7.89 7.73* (3.18–18.76)
OR, odds ratios, CI, confidence intervals; STAI-T, Trait-Anxiety from Spielberger Trait-Anxiety Inventory; ESS, Epworth Sleepiness Scale.
*P £ 0.02.
P £ 0.05.
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Table A4 Fully adjusted associations of depression, with self-reported sleep paralysis, hypnagogic ⁄ hypnopompic hallucinations, automatic be-
havior, and cataplexy in 866 Wisconsin Sleep Cohort Study participants
Sleep paralysis
Hypnagogic ⁄ hypnopompic
hallucinations Automatic behavior Cataplexy
OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value
Depression vs. Zung <50 (ref) 2.90 (1.43–5.87) 0.003 2.32 (1.27–4.2) 0.006 1.64 (1.06–2.53) 0.03 3.26 (1.33–8.01) 0.01
Antidepressant use vs. none 1.56 (0.44–1.55) 0.24 1.06 (0.57–1.99) 0.85 1.53 (1.02–2.30) 0.04 1.97 (0.76–5.09) 0.16
Age 0.94 (0.90–0.98) 0.005 0.94 (0.91–0.97) 0.0004 0.97 (0.95–0.99) 0.002 0.96 (0.91–1.01) 0.13
Female vs. male 0.82 (0.44–1.55) 0.55 1.36 (0.83–2.24) 0.22 0.94 (0.68–1.30) 0.71 0.98 (0.42–2.30) 0.96
BMI 1.03 (0.98–1.07) 0.26 1.01 (0.98–1.05) 0.46 1.03 (1.00–1.05) 0.03 1.04 (0.98–1.10) 0.24
Anxiolytic use vs. none 0.65 (0.14–3.09) 0.59 0.46 (0.10–2.12) 0.32 1.10 (0.49–2.44) 0.82 1.74 (0.43–7.14) 0.44
HLA DQB1*0602§ vs. no alleles 1.47 (0.76–2.87) 0.25 0.89 (0.50–1.58) 0.68 1.09 (0.76–1.56) 0.65 0.83 (0.30–2.28) 0.71
OR, odds ratios; CI, confidence intervals; BMI, body mass index measured as weight (kg) ⁄ height (m2); HLA, human leukocyte antigen.
Odds ratios estimated from four multiple logistic regression models.
Depression defined as Zung score ‡50.
§HLA DQB1*0602 defined as presence of one or two alleles.
Table A5a Unadjusted associations* of depression with sleep paralysis in overall sample and in subgroups without and with hypnagogic ⁄ hyp-
nopompic hallucinations (HH) in the Wisconsin Sleep Cohort Study
Sleep paralysis
Total sample (without and
with HH) (n = 866)
Subgroup without HH
(n = 791)
Subgroup with HH (n = 75)
OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value
Depression (Zung score ‡50) vs. Zung <50 3.11 (1.60–6.05) 0.0008 3.00 (1.39–6.45) 0.005 2.22 (0.55–8.93) 0.26
Table A5b Unadjusted associations* of depression with hypnagogic ⁄ hypnopompic hallucinations (HH) in overall sample and in subgroups
without and with sleep paralysis in the Wisconsin Sleep Cohort Study
Hypnagogic ⁄ hypnopompic hallucinations
Total sample (without and
with SP) (n = 866)
Subgroup without sleep para-
lysis (n = 821)
Subgroup with sleep paralysis
(n = 45)
OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value
Depression (Zung score ‡50) vs. Zung <50 2.37 (1.35–4.16) 0.003 2.25 (1.21–4.17) 0.01 1.67 (0.39–7.19) 0.49
OR, odds ratios; CI, confidence intervals. Sleep paralysis (self-reported) was defined as being unable to move your body and feeling paralyzed
>few times ever either upon awakening in the morning (AM) and ⁄ or awakening during night sleep. Hypnagogic ⁄ hypnopompic hallucinations
(self-reported) was defined as hearing or seeing strange and frightening things or people >few times ever either with sleep onset PM and ⁄ or
awakening AM and ⁄ or when drowsy.
*Odds ratios estimated from logistic regression models.
Table A6 Adjusted associations of depression · anxiety with self-reported cataplexy
b coefficient estimate Standard error P-value
Interaction model 7B: adjusted for antidepressants (n = 866)
Intercept )3.3204 1.8897 0.08
Depression* 2.1840 0.6534 0.0008
Trait anxiety 1.1638 0.5496 0.03
Depression · trait anxiety )2.0475 0.8819 0.02
Age )0.0387 0.0287 0.18
Female )0.0160 0.4357 0.97
Antidepressant use 0.7091 0.4545 0.12
Body mass index 0.0339 0.0339 0.25
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Table A6 (continued)
b coefficient estimate Standard error P-value
Interaction model 7C: excluding antidepressant users (n = 709)
Intercept )3.1594 2.3296 0.13
Depression* 2.2305 0.8532 0.009
Trait anxiety 1.2136 0.6542 0.069
Depression · trait anxiety )2.4600 1.2377 0.05
Age )0.0365 0.0364 0.32
Female )0.8619 0.5679 0.13
Body mass index 0.0489 0.0319 0.13
*Depression defined as Zung score ‡50. Trait anxiety defined as ‡75th percentile on trait anxiety scale of Spielberger State-Trait Anxiety Scale.
Body mass index measured in kg ⁄m2.
Table A7 Rate of depression* in self-reported cataplexy stratified by anxiety
Prevalence of self-reported cataplexy
No anxiety Anxiety
Depression (entire population, n ¼ 866)
No 9/634 (1.4%) 6/114 (5.3%)
Yes 4/31 (12.9%) 6/87 (6.9%)
P-value < 0.0001 0.63




*Depression defined as Zung score ‡50. No depression as Zung score <50.
Anxiety defined as trait anxiety (STAI-T ‡ 75th percentile or a score of ‡39).
No anxiety defined as STAI-T <75th percentile.
Table A8 Adjusted relationship of depression to self-reported cataplexy with laughter and ⁄ or with joking but not with anger in 866 Wisconsin
Sleep Cohort participants
Self-reported cataplexy with laughter and ⁄ or joking
Odds ratio (95% confidence interval) P-value
Depression (Zung score ‡50) vs. Zung score <50 (reference) 4.03 (1.35–12.02) 0.01
Adjusted for age, sex, body mass index, antidepressant use, anxiolytic use and HLA DQB1*0602.
Cataplexy with anger excluded from the definition of cataplexy, leaving 16 participants with cataplexy with joking and ⁄ or laughter but not anger.
The corresponding odds ratio for the same logistic regression model when cataplexy was defined as with laugher and ⁄ or with joking and ⁄ or with
anger was similar: OR 3.26, 95% CI 3.26–8.01, P = 0.01.
312 M. Szklo-Coxe et al.
 2007 European Sleep Research Society, J. Sleep Res., 16, 297–312
